Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-H5N1 virus intracellular antibody PTD-3F-mFc and application of anti-H5N1 virus intracellular antibody PTD-3F-mFc

A technology of 1. ptd-3f-mfc, 2. ptd-3f-mfc, applied in the application field of preparing anti-H5N1 type human avian influenza virus drugs

Active Publication Date: 2020-10-09
ACAD OF MILITARY SCI PLA CHINA ACAD OF MILITARY MEDICAL SCI INST OF MILITARY VETERINARY MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

M1 protein antibody can produce antiviral activity against various subtypes of avian influenza virus, but H5N1 virus replicates and packages in the cell, and M1 protein is located inside the viral envelope, so the antibody needs to enter the infected cell to exert antiviral effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-H5N1 virus intracellular antibody PTD-3F-mFc and application of anti-H5N1 virus intracellular antibody PTD-3F-mFc
  • Anti-H5N1 virus intracellular antibody PTD-3F-mFc and application of anti-H5N1 virus intracellular antibody PTD-3F-mFc
  • Anti-H5N1 virus intracellular antibody PTD-3F-mFc and application of anti-H5N1 virus intracellular antibody PTD-3F-mFc

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1 Construction and expression of M1 recombinant expression plasmid pET-SUMO-M1 and purification of M1 protein

[0021] Design and synthesize specific primers P1 and P2 for the M1 protein, use the H5N1 virus cDNA as a template to PCR amplify the M1 protein gene, and clone it into the PET-SUMO vector to construct the plasmid pET-SUMO-M1, and then transfer it into the T-shot sensory Initial screening was carried out on the agar plate containing kanamycin resistance; a single colony was selected and cultured in LB liquid medium; the plasmid was extracted with a plasmid recovery kit and identified by PCR, and the product was analyzed by 1% agarose gel electrophoresis. A band of about 750 bp was obtained, the size of which was consistent with the inserted target gene, and the sequence was determined to prove that the target fragment was correctly inserted into the vector, and the recombinant plasmid pET-SUMO-M1 was successfully constructed.

[0022]The recombinant pla...

Embodiment 2

[0024] Example 2 Amplification of phage single-chain antibody library

[0025] Inject all the frozen Tomlinson I and J libraries into 200 mL 2×TY medium (containing 100 µg / mL Amp and 1% glucose), and culture with shaking at 37°C until the OD600 value is about 0.4, from Take out 50 mL bacterial liquid from the culture medium, add 2×10 11 The helper phage KM13 was placed in a water bath at 37°C for 30 minutes, centrifuged at 3000×g for 10 minutes at 4°C, and the pellet was resuspended with 50 mL of 2×TY medium (containing 100 µg / mL Amp, 50 µg / mL Kan and 0.1% glucose). Suspended and cultured overnight at 30°C with shaking. Centrifuge the overnight product at 4°C, 3500×g for 30 min, collect 40 mL of the supernatant, add 10 mL of ice-cold PEG / NaCl solution (final concentration is 20% PEG-6000, 2.5 mol / L NaCl), mix well and store on ice Place for more than 1 h, centrifuge at 4°C, 3500×g for 30 min, discard the PEG / NaCl solution, resuspend the pellet in 2 mL of PBS, centrifuge at 1...

Embodiment 3

[0026] Example 3 Screening of anti-M1-scFv

[0027] Coat the purified M1 protein on a 96-well microtiter plate overnight at 4°C. Discard the supernatant the next day, block with 2% Milk-PBS at 37°C for 2 hours, add the prepared secondary phage antibody library, incubate with vigorous shaking at room temperature for 60 minutes, discard the liquid after standing for 60 minutes, and replace with PBS containing 0.1% Tween-20 Wash 10 times, after washing, gently pat dry the remaining liquid in each well, add 50 µL eluent (5 mg / mL trypsin-PBS) to each well, shake vigorously at room temperature for 10 min, elute phage, collect and store at 4 °C .

[0028] Infect E.coli TG1 with the eluted phage, spread on TYE plates (containing 100 μg / mL ampicillin and 1% glucose) and culture overnight at 37°C. The phage library was amplified using the helper phage KM13, and the phage were recovered by PEG / NaCl. Repeat the above process 3 times, a total of 4 rounds of screening.

[0029] Phage in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-H5N1 virus intracellular antibody PTD-3F-mFc. A base sequence of the anti-H5N1 virus intracellular antibody PTD-3F-mFc is as shown in a sequence table SEQID NO.7. The invention also discloses a preparation method of the anti-H5N1 virus intracellular antibody PTD-3F-mFc. The preparation method comprises the following steps: according to an Fc gene sequence of human IgG, designing a CH2-CH3 gene sequence for mutating cysteine in a hinge region; designing a gene sequence, inserting corresponding incision enzyme digestion sites among all the components to facilitatesubsequent gene operation, artificially synthesizing the designed gene sequence, and connecting the synthesized gene into a PTS expression vector constructed in the earlier stage to construct a PTS-mFc expression vector; on the basis, cloning and constructing a PTS-PTD-3F-mFc expression vector again, converting the constructed expression vector into escherichia coli, carrying out induced expression and purification, comparing the antiviral activity of the expression vector, and preferably selecting a single-molecule intracellular antibody. The invention also discloses application of the monomolecular antibody in preparation of anti-H5N1 human avian influenza virus drugs. The result shows that the titer of the PTD-3F-mFc for resisting the H5N1 virus is 600 TCID50.

Description

technical field [0001] The invention belongs to the fields of bioengineering and prevention and treatment of major infectious diseases, and in particular relates to the preparation of anti-highly pathogenic avian influenza H5N1 virus fully human single-molecule intracellular antibody PTD-3F-mFc, and the preparation of anti-H5N1 type human avian influenza virus drugs. application. Background technique [0002] Human infection with highly pathogenic avian influenza (referred to as human avian influenza) is a systemic or respiratory infectious disease caused by type A influenza virus H5N1, with a fatality rate of over 60%. Under natural circumstances, the host range of influenza virus infection has certain specificity, based on which viruses can be divided into different groups, such as human influenza, avian influenza, swine influenza, etc., but the boundary of the host range of influenza virus infection is not very strict , the virus can spread between different species. Si...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/62C12N15/70A61K39/42A61K47/64A61P31/16
CPCC07K16/1018C12N15/70A61K47/64A61P31/16C07K2317/24C07K2317/92C07K2317/622C07K2317/76C07K2319/10Y02A50/30
Inventor 张国利高玉伟刘楚含田园岳玉环邓欣吴广谋李泽鸿王铁成刘雨玲雍伟卢士伟那漫孙赫
Owner ACAD OF MILITARY SCI PLA CHINA ACAD OF MILITARY MEDICAL SCI INST OF MILITARY VETERINARY MEDICINE